SCHEMBL27409232

SCHEMBL27409232

N#Cc1c[nH]c2c(NCc3ccc(B(O)O)cc3)ncnc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 1/20 0.39
EGFR P00533 2/20 0.38
CHUK O15111 1/20 0.38
MAPK1 P28482 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 2/20 0.38
TSHR P16473 2/20 0.38
LMNA P02545 1/20 0.38
CDK2 P24941 1/20 0.38
CCNB2 O95067 1/20 0.36
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
CCNB3 Q8WWL7 1/20 0.36
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
OXTR P30559 1/20 0.36
ABCC1 P33527 1/20 0.36
ABCG2 Q9UNQ0 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30097237 0.83 PRMT1 (0.41) PRMT1EGFRMAPK1CYP1A2CYP2D6
SCHEMBL27410555 0.83 PRMT1 (0.41) PRMT1EGFRMAPK1CYP1A2CYP2D6
SCHEMBL27409830 0.79 RPS6KB1 (0.48) AURKARPS6KB1AURKB
SCHEMBL30097217 0.79 RPS6KB1 (0.48) AURKARPS6KB1AURKB
SCHEMBL27410545 0.78 EGFR (0.42) PRMT1EGFRMAPK1CYP1A2CYP2D6
SCHEMBL30097224 0.78 EGFR (0.42) PRMT1EGFRMAPK1CYP1A2CYP2D6
SCHEMBL30955161 0.77 EGFR (0.38) EGFRMAPK1CYP1A2CYP2D6TSHR
SCHEMBL27409462 0.77 EGFR (0.38) EGFRMAPK1CYP1A2CYP2D6TSHR
SCHEMBL30097159 0.77 AURKA (0.40) PRMT1EGFRMAPK1CYP1A2CYP2D6
SCHEMBL27409242 0.77 AURKA (0.40) PRMT1EGFRMAPK1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS RIBOSCIENCE LLC 2024-06-27 US disclosed
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS RIBOSCIENCE LLC 2024-06-27 US disclosed
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS RIBOSCIENCE LLC 2024-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS ENPP1, ENPP3, ENTPD5 PRMT1 1246/4885EGFR 4139/4885CHUK 581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.